We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Medtronic PLC | NYSE:MDT | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 80.89 | 46 | 12:47:13 |
By Ezequiel Minaya Medtronic PLC said Tuesday it has agreed to acquire Twelve Inc., a
company that develops valve replacement devices, for $458 million.
Redwood City, Calif.-based Twelve is focused on developing a transcatheter mitral valve replacement device, an area Medtronic hopes will be a source of growth.
"We have followed the transcatheter mitral valve space closely and firmly believe that Twelve has the most novel technology along with a strong, proven team," said Sean Salmon, a senior vice president at Medtronic and head of its coronary and structural heart division.
The transaction, expected to close in October, is for $408 million at closing and a $50 million milestone payment.
The Ireland-based Medtronic expects the deal to be earnings neutral as the company intends to offset the dilutive impact of the transaction. Twelve will join Medtronic's coronary and structural heart division within the cardiac and vascular group.
Medtronic relocated to Dublin earlier this year as part of a wave of similar moves aimed at taking advantage of lower corporate-tax rates overseas.
Write to Ezequiel Minaya at ezequiel.minaya@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
August 25, 2015 10:03 ET (14:03 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year Medtronic Chart |
1 Month Medtronic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions